Pemetrexed: all 524 studies that test it

Page 2 of 6. Open to participants first (73), then studies with results posted, then the rest; newest registration first within each.

• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02574078Phase 1/2Results posted
• An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02477826Phase 3Results posted
• Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3CompletedNCT02426658Phase 2Results posted
• A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural MesotheliomaCompletedNCT02347917Phase 1/2Results posted
• A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the LungCompletedNCT02185690Phase 1Results posted
• A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)CompletedNCT02039674Phase 1/2Results posted
• Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)CompletedNCT01982955Phase 1/2Results posted
• Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01918761Phase 1Results posted
• Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung CancerTerminatedNCT01860040Phase 2Results posted
• Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung AdenocarcinomaCompletedNCT01565538Phase 2Results posted
• A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01473563Phase 2Results posted
• A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01469000Phase 2Results posted
• Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)CompletedNCT01454102Phase 1Results posted
• Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)CompletedNCT01443078Phase 2Results posted
• GSK1120212 Rollover StudyTerminatedNCT01376310Phase 2Results posted
• Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersCompletedNCT01344824Phase 2Results posted
• Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate CancerCompletedNCT01338792Phase 2Results posted
• A Study of LY2090314 in Patients With Advanced or Metastatic CancerCompletedNCT01287520Phase 1Results posted
• A Phase 1 Study in Patients With Solid TumorsCompletedNCT01215916Phase 1Results posted
• Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive StrategyCompletedNCT01209520Not applicableResults posted
• A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung CancerCompletedNCT01165021Phase 2Results posted
• A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01160744Phase 2Results posted
• Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLCTerminatedNCT01088906Phase 2Results posted
• A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01087970Phase 2Results posted
• Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line ChemotherapyCompletedNCT01085630Phase 2Results posted
• A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01057589Phase 2Results posted
• Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLCCompletedNCT01042288Phase 2Results posted
• A Study in Non-squamous Non Small Cell Lung Cancer in Asian PatientsCompletedNCT01020786Phase 4Results posted
• A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung CancerCompletedNCT01017874Phase 3Results posted
• A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung CancerCompletedNCT01005680Phase 3Results posted
• A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell CancerCompletedNCT01004250Phase 2Results posted
• Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01001910Phase 2Results posted
• A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung CancerCompletedNCT01000480Phase 2Results posted
• A Study of Cisplatin + Pemetrexed + Avastin as First-Line TherapyTerminatedNCT00998166Phase 2Results posted
• A Study of Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00988858Phase 2Results posted
• Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung CancerCompletedNCT00976456Phase 3Results posted
• AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT00961415Phase 3Results posted
• Study of Participants With Advanced Non-Small Cell Lung CancerCompletedNCT00948675Phase 3Results posted
• Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00942825Phase 2Results posted
• Sirolimus and Pemetrexed to Treat Non-Small Cell Lung CancerTerminatedNCT00923273Phase 1/2Results posted
• Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung CancerTerminatedNCT00921310Phase 1/2Results posted
• Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung CancerCompletedNCT00906282Phase 2Results posted
• A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung CancerCompletedNCT00887549Phase 2Results posted
• Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung CancerCompletedNCT00871403Phase 2Results posted
• Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal CarcinomaCompletedNCT00868192Phase 2Results posted
• A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung CancerCompletedNCT00867009Phase 2Results posted
• Study of Pemetrexed for Second-Line Pancreas CancerTerminatedNCT00864513Phase 2Results posted
• Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTerminatedNCT00863512Phase 3Results posted
• Alimta Plus Gemcitabine for Advanced SarcomaCompletedNCT00860015Phase 2Results posted
• Trimodal Lung-Sparing Treatment of Pleural MesotheliomaTerminatedNCT00859495Phase 2Results posted
• Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentCompletedNCT00807573Phase 2Results posted
• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCCompletedNCT00806819Phase 3Results posted
• A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced CarcinomaTerminatedNCT00794417Phase 1/2Results posted
• A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung CancerCompletedNCT00789373Phase 3Results posted
• A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00762034Phase 3Results posted
• Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerTerminatedNCT00738881Phase 3Results posted
• An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural MesotheliomaCompletedNCT00738582Phase 2Results posted
• A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid MalignanciesCompletedNCT00732992Phase 1Results posted
• Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung CancerTerminatedNCT00732303Phase 2Results posted
• Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian CancerCompletedNCT00702299Phase 1Results posted
• Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)CompletedNCT00700336Phase 1/2Results posted
• Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00698815Phase 2Results posted
• Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerCompletedNCT00686959Phase 3Results posted
• Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung CancerCompletedNCT00614822Phase 2Results posted
• Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemTerminatedNCT00612677Phase 2Results posted
• A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT00606021Phase 2Results posted
• Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)TerminatedNCT00604461Phase 1/2Results posted
• A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)CompletedNCT00589667Phase 2Results posted
• A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00550173Phase 2Results posted
• Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung CancerTerminatedNCT00545948Phase 2Results posted
• Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung CancerCompletedNCT00529100Phase 1/2Results posted
• Chemotherapy for Patients With OsteosarcomaCompletedNCT00523419Phase 2Results posted
• A Study of Pemetrexed in Children With Recurrent CancerCompletedNCT00520936Phase 2Results posted
• Chemotherapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00520676Phase 3Results posted
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLCCompletedNCT00517595Phase 2Results posted
• Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00509366Phase 2Results posted
• Single Agent Alimta in Poor Performance Status in Non-small Cell Lung CancerCompletedNCT00508144Phase 2Results posted
• Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00503997Phase 2Results posted
• Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)TerminatedNCT00494026Phase 2Results posted
• Pemetrexed Plus Gemcitabine in Renal Cell CancerTerminatedNCT00491075Phase 2Results posted
• Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal CancerCompletedNCT00489359Phase 1/2Results posted
• Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00487669Phase 2Results posted
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung CancerTerminatedNCT00475657Phase 2Results posted
• Abraxane and Alimta in Advanced Solid TumorsTerminatedNCT00470548Phase 1/2Results posted
• A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerCompletedNCT00461786Phase 2Results posted
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
• A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and RadiotherapyTerminatedNCT00447421Phase 1/2Results posted
• Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00438204Phase 2Results posted
• Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With CancerCompletedNCT00415636Phase 1Results posted
• A Study for Patients With Head and Neck CancerCompletedNCT00415194Phase 3Results posted
• Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric CancerCompletedNCT00415168Phase 2Results posted
• AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung CancerCompletedNCT00410904Phase 2Results posted
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00407550Phase 2Results posted
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung CancerTerminatedNCT00402883Phase 2Results posted
• Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck CancerTerminatedNCT00394147Phase 2Results posted
• Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00391274Phase 3Results posted
• Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00389805Phase 1/2Results posted
• Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung CancerTerminatedNCT00383331Phase 2Results posted
• A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal CancerTerminatedNCT00383266Phase 2Results posted
• Chemotherapy for Patients With Non-Small Cell Lung CancerCompletedNCT00380718Phase 4Results posted

← Pemetrexed overview